|
News Feeds from
"Medical News Today"
Autism News
The news and information from
Medical News Today are widely recognized as being timely,
accurate and unbiased - with no affiliations or connections to
any other organizations (media or otherwise).
Here
MedRat®
BioArchives
presents
the latest news feeds from Medical News Today encompassing
Autism News.
Autism News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
New York State Approves Quest Diagnostics' Fragile X Syndrome Test
29 Jul 2010 at 3:00am
An accurate, faster testing option to identify female carriers and other patients with genetic abnormalities that cause Fragile X Syndrome is now available to physicians in all fifty states with the recent approval in New York. Fragile X is the leading cause of inherited mental retardation and the most common known single gene cause of autism...
Curemark Opens Autism Trials At New Jersey Site
29 Jul 2010 at 3:00am
Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that Saint Peter's University Hospital in New Brunswick, New Jersey, is participating in the company's Phase III clinical trials for CM-AT, Curemark's autism treatment. Saint Peter's is affiliated with the Drexel University College of Medicine in Philadelphia...
Autism Charity Raises The Bar For Legal Campaigning, UK
29 Jul 2010 at 2:00am
The National Autistic Society (NAS) has ramped up its legal campaigning with the launch of a new Autism Legal Network and a call for cases with the potential to change the law for the half a million people with autism in the UK. Mark Lever, chief executive of the NAS said; "The NAS is evolving. Last year we successfully secured the landmark Autism Act...
Seaside Therapeutics Reports Data From Randomized, Placebo-Controlled Phase 2...
28 Jul 2010 at 2:00am
Seaside Therapeutics, Inc. announced data from the largest randomized, placebo-controlled study conducted to date in individuals with fragile X syndrome. In a Phase 2 study of STX209, clinically meaningful improvements on global and specific neurobehavioral outcomes were observed in the general study population...
Asuragen And Collaborators Report Results Using PCR-Only Technologies For The...
27 Jul 2010 at 1:00am
Asuragen, Inc. announced the results from two collaborative studies, one with the University of California Davis M.I.N.D. Institute and another with Rush University Medical Center, that demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation (FMR1) gene using advanced PCR-based methods...
XenoPort Announces Presentation Of Preclinical Data For Acamprosate Prodrug A...
27 Jul 2010 at 1:00am
XenoPort, Inc. (Nasdaq:XNPT) announced that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical data on this new product candidate will be presented at the National Fragile X Foundation's 12th International Fragile X Conference in Detroit, Michigan...
Leading Researchers To Share New Treatments At Fragile X International Confer...
23 Jul 2010 at 4:00am
Accelerated research findings leading to potentially significant new treatments for fragile X syndrome (FXS) will be presented to nearly 1,000 family members and professionals at the 12th International Fragile X Conference in Dearborn July 21-25...
New Survey By Enzymedica Links Autism & Digestion, Suggests Successful Strate...
23 Jul 2010 at 1:00am
Autism is the fastest growing developmental disorder in the world. With 1 child in 91 facing the disorder, the diagnosis is more common than pediatric cancer, diabetes, and AIDS combined...
A National Autistic Society Response To The Commission On The Funding Of Care...
21 Jul 2010 at 11:00am
The National Autistic Society (NAS) has welcomed the establishment of the Commission on the Funding of Care and Support today, but urged that it must consider how to fund support for those with lifelong conditions, such as autism, who are less able to save and pay for their social care...
Autism Detected In Unique Vocal Signature Of Baby Talk
21 Jul 2010 at 10:00am
Using a new type of "vocal signature" technology that focuses on sound patterns rather than words in child vocalizations and baby talk, researchers in the US say they have proved in principle that it is possible to screen for autism spectrum disorders in young children; they also hope the new method will greatly enhance the study of language development because it...
New Technology Reveals A Unique Vocal Signature In Autism
20 Jul 2010 at 5:00am
A new automated vocal analysis technology could fundamentally change the study of language development as well as the screening for autism spectrum disorders and language delay, reports a study in the July 19 online Proceedings of the National Academy of Sciences...
Dietary Issues In Children With Autism Spectrum Disorders
20 Jul 2010 at 2:00am
Children with autism spectrum disorders (ASD) can demonstrate feeding problems, food refusal, and limited food preferences from infancy, but energy intake and growth are not affected...
Closer To A Treatment For Autism
15 Jul 2010 at 2:00am
Rubicon winner Dalila Pinto discovered a copying error in the DNA of trial subjects who suffered from autism or a similar condition. Some segments of their DNA were copied either once too often or missed out of the copying process. This is a highly promising result from the world's largest investigation into autism. The top journal Nature placed the results online on 9 June...
Calif., R.I., Move To Strengthen Review Of Health Insurance Rates; Ind. Weigh...
9 Jul 2010 at 5:00am
The Los Angeles Times' Blog: "Gov. Arnold Schwarzenegger moved Wednesday to implement a major element of the new national healthcare overhaul, seeking a $1-million federal grant to strengthen the state's review of health insurance rates. Much of the money would pay for actuaries to evaluate premium hikes sought by insurers. ...
Autism-Related Study Discovers How Drug Interferes With Neuronal Cell Function
8 Jul 2010 at 5:00am
A York University study has shown for the first time how the drug misoprostol, which has been linked to neurodevelopmental defects associated with autism, interferes with neuronal cell function. It is an important finding because misoprostol is similar in structure to naturally-occurring prostaglandins, which are the key signaling molecules produced by fatty acids in the brain...
Presented by MedRat®
|
|
